Home » Topics » BioWorld Science

BioWorld Science
RSS

Biovail's diltiazem covered under U.S. patent

Aug. 9, 1996

Status update of Recordati's lercanidipine HCl

Aug. 9, 1996

SmithKline Beecham and Meiji Seika to comarket levcromakalim

Aug. 9, 1996

Eisai terminates E-4177 development

Aug. 9, 1996

Renin inhibitors described by Ciba-Geigy

Aug. 9, 1996

KRH-594: Wakunaga's angiotensin II antagonist

Aug. 9, 1996

Angiotensin II antagonists disclosed by Tanabe Seiyaku

Aug. 9, 1996

Cyclohexapeptides with multiple utilities reported by Hoechst

Aug. 9, 1996

Serine protease inhibitors in Teijin's R&D pipeline

Aug. 9, 1996

Potent 5-lipoxygenase inhibitors from Yakult Honsha

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...